相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Should all eligible patients with multiple myeloma receive autologous stem-cell transplant as part of initial treatment?
Philippe Moreau et al.
LEUKEMIA RESEARCH (2012)
Achievement of VGPR to induction therapy is an important prognostic factor for longer PFS in the IFM 2005-01 trial
Philippe Moreau et al.
BLOOD (2011)
Consensus recommendations for the uniform reporting of clinical trials: report of the International Myeloma Workshop Consensus Panel 1
S. Vincent Rajkumar et al.
BLOOD (2011)
Complete response correlates with long-term progression-free and overall survival in elderly myeloma treated with novel agents: analysis of 1175 patients
Francesca Gay et al.
BLOOD (2011)
Comparison of Immunofixation, Serum Free Light Chain, and Immunophenotyping for Response Evaluation and Prognostication in Multiple Myeloma
Bruno Paiva et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Superior outcomes associated with complete response in newly diagnosed multiple myeloma patients treated with nonintensive therapy: analysis of the phase 3 VISTA study of bortezomib plus melphalan-prednisone versus melphalan-prednisone
Jean-Luc Harousseau et al.
BLOOD (2010)
Serum immunoglobulin free light-chain measurement in primary amyloidosis: prognostic value and correlations with clinical features
Shaji Kumar et al.
BLOOD (2010)
Major Tumor Shrinking and Persistent Molecular Remissions After Consolidation With Bortezomib, Thalidomide, and Dexamethasone in Patients With Autografted Myeloma
Marco Ladetto et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Prevalence and risk of progression of light-chain monoclonal gammopathy of undetermined significance: a retrospective population-based cohort study
Angela Dispenzieri et al.
LANCET (2010)
Minimal Residual Disease in Acute Lymphoblastic Leukemia
Dario Campana
HEMATOLOGY-AMERICAN SOCIETY HEMATOLOGY EDUCATION PROGRAM (2010)
Whole-Body MRI Versus PET in Assessment of Multiple Myeloma Disease Activity
Conor P. Shortt et al.
AMERICAN JOURNAL OF ROENTGENOLOGY (2009)
The relationship between the serum free light chain assay and serum immunofixation electrophoresis, and the definition of concordant and discordant free light chain ratios
Seema Singhal et al.
BLOOD (2009)
Serum Free Light Chain Ratio, Total κ/λ Ratio, and Immunofixation Results Are Not Prognostic Factors after Stem Cell Transplantation for Newly Diagnosed Multiple Myeloma
Manuela M. Giarin et al.
CLINICAL CHEMISTRY (2009)
Multiparameter flow cytometry quantification of bone marrow plasma cells at diagnosis provides more prognostic information than morphological assessment in myeloma patients
Bruno Paiva et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2009)
Achievement of at Least Very Good Partial Response Is a Simple and Robust Prognostic Factor in Patients With Multiple Myeloma Treated With High-Dose Therapy: Long-Term Analysis of the IFM 99-02 and 99-04 Trials
Jean-Luc Harousseau et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders
A. Dispenzieri et al.
LEUKEMIA (2009)
Criteria for diagnosis, staging, risk stratification and response assessment of multiple myeloma
R. A. Kyle et al.
LEUKEMIA (2009)
International Myeloma Working Group molecular classification of multiple myeloma: spotlight review
R. Fonseca et al.
LEUKEMIA (2009)
Appraisal of immunoglobulin free light chain as a marker of response
Angela Dispenzieri et al.
BLOOD (2008)
The evolving use of serum free light chain assays in haematology
Guy Pratt
BRITISH JOURNAL OF HAEMATOLOGY (2008)
Complete response correlates with long-term survival and progression-free survival in high-dose therapy in multiple myeloma
Helgi J. K. van de Velde et al.
HAEMATOLOGICA (2007)
International uniform response criteria for multiple myeloma
B. G. M. Durie et al.
LEUKEMIA (2006)
Monitoring CML patients responding to treatment with tyrosine kinase inhibitors:: review and recommendations for harmonizing current methodology for detecting BCR-ABL transcripts and kinase domain mutations and for expressing results
Timothy Hughes et al.
BLOOD (2006)
Diverse niches within multiple myeloma bone marrow aspirates affect plasma cell enumeration
L Nadav et al.
BRITISH JOURNAL OF HAEMATOLOGY (2006)
Serum free light chains for monitoring multiple myeloma
GP Mead et al.
BRITISH JOURNAL OF HAEMATOLOGY (2004)
Magnitude of response with myeloma frontline therapy does not predict outcome: Importance of time to progression in southwest oncology group chemotherapy trials
BGM Durie et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
The impact of attaining a minimal disease state after high-dose melphalan and autologous transplantation for multiple myeloma
FE Davies et al.
BRITISH JOURNAL OF HAEMATOLOGY (2001)
分享论文
